5 minutes with: Dr Dorothy Lombe
Dr Dorothy Lombe is a clinical and radiation oncologist at the Cancer Diseases Hospital in Zambia & is a member of the International Task Force […]
5 minutes with: Dr Verna Vanderpuye
Dr Vanderpuye currently practices at the National Center for Radiotherapy, Oncology and Nuclear Medicine, at the Korlebu Teaching Hospital in Accra, Ghana, and is a […]
Towards cervical cancer elimination: DNA methylation as a triage strategy
Today we discuss with Professor Gloria I. Sanchez her latest research into DNA methylation as a triage strategy for women testing HPV positive at the […]
5 minutes with: Dr Zipporah Ali
Dr Zipporah Ali is the Executive Director or of Kenya Hospices and Palliative Care Association (KEHPCA), and a member of the International Task Force on […]
How do we transform cervical cancer screening for the transgender population?
Dr Alison May Berner is a Specialist Trainee and Academic Clinical Fellow in Medical Oncology and part-time Speciality Registrar in Gender Medicine at Barts Cancer […]
The Ageing Soma, Cancer Evolution & Prevention
James DeGregori is a Professor of Biochemistry and Molecular Genetics at the University of Colorado. His lab seeks to understand how carcinogenic conditions promote cancer […]
The Ageing Soma, Screening and All-Cause Mortality
Paul Pharoah is Professor of Cancer Epidemiology at the University of Cambridge, where he leads research on the molecular pathology of breast and ovarian cancer […]
Five minutes with: Dr Mona Saraiya
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and […]
Finding the optimal HPV test for primary screening and triage in Latin America
In this blog, we speak to Dr Maribel Almonte Pacheco, Prevention and Implementation Group Head at IARC. Dr Almonte is the chief investigator on the […]
Over 99.5% of young women survive following a diagnosis of IA cervical cancer
The earliest stage of cervical cancer (known as micro-invasive or stage IA) is treated with minimally-invasive fertility-preserving surgery, often as an outpatient. In fact, very […]